Merck & Company

Traded on the St. Petersburg Stock Exchange
Merck & Co., outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. It produces vaccines and other drugs, and publishes health information publications on a non-profit basis, such as the Merck Index, a compendium of chemical compounds, and The Merck Manuals, a series of medical reference books for physicians, nurses, technicians, and veterinarians.
Merck & Company stock price chart
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Merck & Company balance sheet

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Merck & Company cash flows

Report period2018 2019 2020 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Merck & Company multipliers

Report period2018 2019 2020 2021 2022 2023
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Merck & Company profitability

Report period2018 2019 2020 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Merck & Company assets
Merck & Company cash flows
Merck & Company dividends
4.46%

Merck & Company shares

TickerNameTypeNominal valueISINPrice
MRK:USMerck & Company Inc. (new)Common share-US58933Y1055$123.8
MRK-RM:RMMerck & CoCommon share$0.5US58933Y1055RUB 4,821

Merck & Company expected events

DateTypeNoteSource
05.04.2024 10:00
Dividends
The company will pay dividends of $0.77 per common share for Q2 Fiscal Year 2024.Pictogram of www.merck.com  www.merck.com
Merck & Company news
26.10.2023
Merck & Company's GAAP net income for 9 months of 2023 amounted to $1.603 billion, down 7.2 times from $11.508 billion in the previous year. Revenue increased 0.1% to $45.485 billion from $45.453 billion a year earlier.
Source: {source} pictogram merck.com
01.08.2023
Merck & Company's GAAP loss for 6 months of 2023 was $3.147 billion, against a profit of $8.256 billion in the prior year. Revenue declined 3.2% to $29.522 billion against $30.494 billion a year earlier.
Source: {source} pictogram merck.com
02.02.2023
Merck & Company's GAAP net income for 2022 was $14.519 billion, up 11.3% from $13.049 billion the previous year. Revenue rose 21.7% to $59.283 billion from $48.704 billion a year earlier.
Source: {source} pictogram merck.com
24.01.2023
The Merck & Company Board of Directors announced a quarterly dividend of $0.73 per share. The last day to buy securities to receive the dividend is March 13, 2023. The annual dividend yield may reach 2.94%.
Source: {source} pictogram merck.com
General information
Company nameMerck & Company
Tags#pharmacy, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Mailing address2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Websiteinvestors.merck.com
Information disclosurewww.sec.gov